Plasma cell-free nucleic acids promise disease monitoring and tissue injury assessment of COVID-19
Abstract
We report gross abnormalities in cfDNA of COVID-19 patients, through parallel analysis of plasma cfDNA and cfRNA during treatment, we demonstrate the translational merit of cell-free nucleic acids as valuable analytes for effective disease monitoring, as well as liquid biopsy of tissue injuries in COVID-19 patients.
Fields of Study & Subjects
Cancer Genomics and Diagnostics
Single-cell and spatial transcriptomics
SARS-CoV-2 detection and testing
Publication details
- Journal / source
- China National GeneBank DataBase
- Publication date
- 1 January 2026
- Language
- EN